TTY Biopharm Company financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
NT$1.58B | NT$2.30B | NT$2.33B | NT$2.81B | NT$2.92B | NT$3.17B | NT$3.44B | NT$3.87B | NT$4.02B | NT$3.11B | NT$2.98B | NT$3.20B | NT$3.76B | NT$4.08B | NT$4.04B | NT$4.47B | NT$4.22B | NT$4.54B | NT$5.06B | NT$0.00M | NT$0.00M |
| GM % | Gross Margin % |
|
68.84% | 59.39% | 58.96% | 60.72% | 61.83% | 61.28% | 64.72% | 62.12% | 62.68% | 66.06% | 63.49% | 68.49% | 67.99% | 65.49% | 66.00% | 65.09% | 61.70% | 61.03% | 59.69% | 0.00% | 0.00% |
| OM | Operating Margin |
|
19.09% | 12.37% | 11.67% | 13.37% | 15.68% | 14.02% | 15.80% | 14.14% | 16.26% | 10.93% | 11.35% | 24.72% | 31.37% | 30.82% | 26.25% | 27.51% | 22.68% | 25.15% | 24.26% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
NT$1.47 | NT$2.10 | NT$2.18 | NT$2.36 | NT$3.13 | NT$4.86 | NT$4.79 | NT$5.40 | NT$5.87 | NT$3.61 | NT$3.71 | NT$3.34 | NT$4.40 | NT$4.90 | NT$0.00 | ||||||
| Div. | Dividends |
|
NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.15 | NT$0.00 | NT$1.20 | NT$1.87 | NT$2.50 | NT$0.00 | NT$3.80 | NT$4.50 | NT$4.50 | NT$4.00 | NT$4.00 | NT$3.00 | NT$3.40 | NT$3.80 | NT$0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 10.20% | 0 | 55.05% | 79.24% | 79.87% | 0 | 79.33% | 83.33% | 76.66% | 110.80% | 107.82% | 89.82% | 77.27% | 77.55% | 0 |
| Sha. | Shares |
|
212.62m | 216.56m | 217.7m | 228.76m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 248.65m | 0m | 0m |
| OCF | Operating Cash Flow |
|
NT$299.26M | NT$186.15M | NT$348.02M | NT$424.82M | NT$385.63M | NT$501.41M | NT$373.33M | NT$622.41M | NT$123.89M | NT$534.77M | NT$577.95M | NT$639.20M | NT$1.23B | NT$996.52M | NT$1.07B | NT$1.21B | NT$526.35M | NT$1.26B | NT$1.24B | NT$0.00M | NT$0.00M |
| FCF | Free Cash Flow |
|
NT$269.50M | NT$71.09M | NT$284.20M | NT$268.16M | NT$254.21M | NT$327.10M | NT$-99.22M | NT$-220.48M | NT$-189.97M | NT$258.57M | NT$146.88M | NT$462.40M | NT$608.64M | NT$899.84M | NT$999.70M | NT$1.16B | NT$358.25M | NT$1.20B | NT$1.14B | NT$1.01B | NT$0.00M |
| FCFS | Free Cash Flow Per Share |
|
NT$1.23 | NT$0.06 | NT$1.06 | NT$1.35 | NT$1.02 | NT$1.31 | NT$-0.46 | NT$-0.92 | NT$-0.87 | NT$0.20 | NT$-0.44 | NT$1.83 | NT$4.52 | NT$3.62 | NT$3.97 | NT$4.58 | NT$1.39 | NT$4.75 | NT$4.42 | NT$0.00 | NT$0.00 |